TickerFactsScreenerDevelopers

NEOGENOMICS INC (NEO) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2016: $133.70M2017: $138.29M2018: $149.48M2019: $211.99M2020: $258.56M2021: $297.27M2022: $321.83M2023: $347.04M2024: $370.47M2025: $413.04M$413.04M
2016Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$413.04M+11.5%
2024$370.47M+6.8%
2023$347.04M+7.8%
2022$321.83M+8.3%
2021$297.27M+15.0%
2020$258.56M+22.0%
2019$211.99M+41.8%
2018$149.48M+8.1%
2017$138.29M+3.4%
2016$133.70M—